Then we constructed the CRISPR-dCas9-KRAB system driven by the PSA promoter, which can inhibit PSA gene expression in cells at the transcriptional level, and therefore suppress the malignant growth and migration of prostate cancer cells and promote their apoptosis. The gene discussed is KLK3; the disease is prostate cancer.